Paper20005149
CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis.
Zhang J and 2 others. Cytokine Growth Factor Rev, 2010. Cited by 221 papers, by iCite.
Cite this record
ConductScience Library. CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis. Papers, record 20005149. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20005149
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chemokine CCL2 | Major topic |
| Prostatic Neoplasms | Major topic |
| Animals | |
| Cell Proliferation | |
| Cell Survival | |
| Humans | |
| Lymphocytes, Tumor-Infiltrating | |
| Macrophages | |
| Male | |
| Models, Biological | |
| Neovascularization, Pathologic | |
| Osteoclasts | |
| Receptors, CCR2 |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA46592 | NCI NIH HHS | United States | P30CA046592 | PubMed and NIH | NIH RePORTER |
| U10 CA032102 | NCI NIH HHS | United States | U10CA032102 | PubMed and NIH | NIH RePORTER |
| NIH SPORE P50 CA69568 | NCI NIH HHS | United States | PubMed | PubMed | |
| P50 CA069568 | NCI NIH HHS | United States | P50CA069568 | PubMed and NIH | NIH RePORTER |
| NIH PO1 CA093900 | NCI NIH HHS | United States | PubMed | PubMed | |
| P01 CA093900 | NCI NIH HHS | United States | P01CA093900 | PubMed and NIH | NIH RePORTER |
| P30 CA046592 | NCI NIH HHS | United States | P30CA046592 | PubMed and NIH | NIH RePORTER |
| N01 CA032102 | NCI NIH HHS | United States | U10CA032102 | PubMed and NIH | NIH RePORTER |
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9252328 | Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. | Science | 1997 | https://conductscience.org/library/papers/9252328 | PubMed |
| 2 | 10898488 | CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. | Eur J Immunol | 2000 | https://conductscience.org/library/papers/10898488 | PubMed |
| 3 | 9365111 | In vivo properties of monocyte chemoattractant protein-1. | J Leukoc Biol | 1997 | https://conductscience.org/library/papers/9365111 | PubMed |
| 4 | 2926329 | Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. | J Exp Med | 1989 | https://conductscience.org/library/papers/2926329 | PubMed |
| 5 | 8760810 | Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. | J Exp Med | 1996 | https://conductscience.org/library/papers/8760810 | PubMed |
| 6 | 18758234 | CCL2, survivin and autophagy: new links with implications in human cancer. | Autophagy | 2008 | https://conductscience.org/library/papers/18758234 | PubMed |
| 7 | 19176388 | A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone. | Cancer Res | 2009 | https://conductscience.org/library/papers/19176388 | PubMed |
| 8 | 10417778 | Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. | Int J Cancer | 1999 | https://conductscience.org/library/papers/10417778 | PubMed |
| 9 | 15888256 | IL-10 enhances CCL2 release and chemotaxis induced by CCL16 in human monocytes. | Int J Immunopathol Pharmacol | 2005 | https://conductscience.org/library/papers/15888256 | PubMed |
| 10 | 17710158 | CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration. | Neoplasia | 2007 | https://conductscience.org/library/papers/17710158 | PubMed |
| 11 | 12495640 | Chemokine biology in cancer. | Semin Immunol | 2003 | https://conductscience.org/library/papers/12495640 | PubMed |
| 12 | 19415685 | FGF-8b induces growth and rich vascularization in an orthotopic PC-3 model of prostate cancer. | J Cell Biochem | 2009 | https://conductscience.org/library/papers/19415685 | PubMed |
| 13 | 19170075 | Prostate cancer promotes CD11b positive cells to differentiate into osteoclasts. | J Cell Biochem | 2009 | https://conductscience.org/library/papers/19170075 | PubMed |
| 14 | 16860609 | T cells and their partners: The chemokine dating agency. | Trends Immunol | 2006 | https://conductscience.org/library/papers/16860609 | PubMed |
| 15 | 9137096 | Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. | Am J Pathol | 1997 | https://conductscience.org/library/papers/9137096 | PubMed |
| 16 | 18611860 | CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18611860 | PubMed |
| 17 | 17094383 | Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients. | Anticancer Res | 2006 | https://conductscience.org/library/papers/17094383 | PubMed |
| 18 | 17942936 | Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. | Cancer Res | 2007 | https://conductscience.org/library/papers/17942936 | PubMed |
| 19 | 16520032 | Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. | Eur J Cancer | 2006 | https://conductscience.org/library/papers/16520032 | PubMed |
| 20 | 2004761 | Localization of monocyte chemotactic protein-1 gene (SCYA2) to human chromosome 17q11.2-q21.1. | Genomics | 1991 | https://conductscience.org/library/papers/2004761 | PubMed |
Cited by159
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 221 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42683198 | Natural Medicines Modulating Tumor Perineural Invasion: Regulatory Mechanisms and Therapeutic Potential. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42683198 | PubMed |
| 42382771 | Immune-tumor cell ligand-receptor axes driving metabolic reprogramming and therapeutic resistance in cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42382771 | PubMed |
| 41169350 | CCL2/CCR2 signaling pathway in tumorigenesis and metastasis (Review). | Oncol Lett | 2025 | https://conductscience.org/library/papers/41169350 | PubMed |
| 41163074 | CRISPR-mediated engineering of mesenchymal stromal/stem cells: a summary of recent progress in immunological applications for regenerative medicine and cancer therapy. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/41163074 | PubMed |
| 40722593 | Analysis of Pro-Inflammatory and Anti-Inflammatory Cytokine Serum Concentrations in Pediatric Patients with Neuroblastoma: A Preliminary Study. | Biomedicines | 2025 | https://conductscience.org/library/papers/40722593 | PubMed |
| 40230862 | Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma. | Front Immunol | 2025 | https://conductscience.org/library/papers/40230862 | PubMed |
| 39996747 | Tumor-Associated Macrophage (TAM)-Related Cytokines, sCD163, CCL2, and CCL4, as Novel Biomarkers for Overall Survival and Time to Treatment in Waldenstrom's Macroglobulinemia: Emphasis on Asymptomatic WM. | Cells | 2025 | https://conductscience.org/library/papers/39996747 | PubMed |
| 39409924 | The Laws of Attraction: Chemokines as Critical Mediators in Cancer Progression and Immunotherapy Response in Bladder Cancer. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39409924 | PubMed |
| 39138521 | M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis. | Exp Hematol Oncol | 2024 | https://conductscience.org/library/papers/39138521 | PubMed |
| 39034318 | Targeting cytokine and chemokine signaling pathways for cancer therapy. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39034318 | PubMed |
| 38703051 | Key players of immunosuppression in epithelial malignancies: Tumor-infiltrating myeloid cells and γδ T cells. | Cancer Rep (Hoboken) | 2024 | https://conductscience.org/library/papers/38703051 | PubMed |
| 38565910 | Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer. | Prostate Cancer Prostatic Dis | 2025 | https://conductscience.org/library/papers/38565910 | PubMed |
| 38525786 | DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer. | Epigenetics | 2024 | https://conductscience.org/library/papers/38525786 | PubMed |
| 38157119 | CCL2 Potentiates Inflammation Pain and Related Anxiety-Like Behavior Through NMDA Signaling in Anterior Cingulate Cortex. | Mol Neurobiol | 2024 | https://conductscience.org/library/papers/38157119 | PubMed |
| 38069225 | Crosstalk between Endothelial Cells and Tumor Cells: A New Era in Prostate Cancer Progression. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38069225 | PubMed |
| 37964011 | Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma. | Sci Rep | 2023 | https://conductscience.org/library/papers/37964011 | PubMed |
| 37296899 | Autotaxin Inhibition with IOA-289 Decreases Breast Tumor Growth in Mice Whereas Knockout of Autotaxin in Adipocytes Does Not. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37296899 | PubMed |
| 37247921 | Attenuative Effect of Diallyl Trisulfide on Caspase Activity in TNF-α-induced Triple Negative Breast Cancer Cells. | Anticancer Res | 2023 | https://conductscience.org/library/papers/37247921 | PubMed |
| 36872292 | Epigenetic regulation of chemokine (CC-motif) ligand 2 in inflammatory diseases. | Cell Prolif | 2023 | https://conductscience.org/library/papers/36872292 | PubMed |
| 36751417 | Abaloparatide Has the Same Catabolic Effects on Bones of Mice When Infused as PTH (1-34). | JBMR Plus | 2023 | https://conductscience.org/library/papers/36751417 | PubMed |
Genes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20005149
GET https://conductscience.org/api/papers/v1/20005149/references?page=2